Sign In
Manage PermissionsManage Permissions

Health Products Founds Adulterated

‚Äč

HEALTH PRODUCTS FOUND ADULTERATED

 

The Ministry of Health would like to alert members of the public to 2 types of health products which have been tested by the Laboratory of Pharmacy Section, Scientific Laboratory Services, Laboratory Services, Ministry of Health and found to be adulterated with undeclared, potent western medicine.


The affected health products are listed as below:

No.Name of productManufacturerAdulterated with
1.Be Fit Slimming & Detox Be Fit CapsuleMalaysiaSibutramine
2.Cala Huala CapsuleLaboratorio Herbal Food SA, PeruIbuprofen, Chlorpheniramine, Simvastatin, Chloramphenicol


(Click here for images)


The adulterant found in this product can cause adverse effects that are potentially hazardous to the people using them.

 

Sibutramine is a slimming agent and is no longer recommended for medical use in obesity due to its harmful effects on the heart and liver. Its consumption can also cause serious adverse reactions such as high blood pressure, heart palpitation, insomnia and in worst cases, kidney and liver damage.

 

Ibuprofen is a pain-relief medicine that, if taken without supervision, may result in peptic ulceration, gastrointestinal bleeding, nausea, vomiting, skin rashes, blurred vision, oedema, jaundice, kidney failure and Stevens-Johnson Syndrome, which is a serious disorder of the skin.

 

Dizziness, lowering of blood pressure, irregular heartbeat, confusion, depression and convulsions are among the adverse effects that could occur from the unsupervised consumption of Chlorpheniramine.

 

Simvastatin is a drug used to lower cholesterol level in the blood. The long term consumption of simvastatin without supervision can cause headache, dizziness, constipation, rash, sleep disturbances, depression, alter the normal liver function, muscle pain and in rare cases, simvastatin can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure.


Chloramphenicol is used in the treatment of bacterial infections. Unsupervised consumption of Chloramphenicol can cause side effects such as blood disorders, depression, diarrhoea, skin rashes, headache, nausea, vomiting, blurred vision, sore throat, breathing difficulties and irreversible aplastic anaemia (a condition that causes damage to the bone marrow resulting in deficiency of all blood cell types).

 

The Ministry of Health has not issued any approval for the importation for the sale of these products. Following these findings, the products are not allowed to be imported and sold in Brunei Darussalam.

 

Members of the public who have purchased or used these products are advised to stop using them immediately. Consumers should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using these products.

 

Members of the public involved in the retail of these products (including online retail such as through Facebook, etc.) are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months' imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months' imprisonment.

 

The Ministry of Health would also like to call upon the public for their cooperation to report to the Health Regulations Services if any of these products are still found on the market in this country.

 

For further information and communication, the public may contact the Health Regulations Services at 2384182, send an e-mail to health.regulations@moh.gov.bn or go directly to the Health Regulations Services, 1st Floor, Ministry of Health, Commonwealth Drive, Brunei Darussalam. The public may also contact Talian Darussalam 123 for any other enquiries.


 - E N D  -


Reference       : KK/PR/3

Date                : 23 September 2017 / 2 Muharram 1439


Attachments